|
1
|
Hendricksen K and Witjes JA: Current
strategies for first and second line intravesical therapy for
nonmuscle invasive bladder cancer. Curr Opin Urol. 17:352–357.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasin E, Josephson DY, Mitra AP, Cote RJ
and Stein JP: Superficial bladder cancer: an update on etiology,
molecular development, classification, and natural history. Rev
Urol. 10:31–43. 2008.PubMed/NCBI
|
|
4
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Bohle A, Palou-Redorta J and Roupret M; European
Association of Urology: EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder, the 2011 update. Eur Urol.
59:997–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luke C, Tracey E, Stapleton A and Roder D:
Exploring contrary trends in bladder cancer incidence, mortality
and survival: implications for research and cancer control. Intern
Med J. 40:357–362. 2010. View Article : Google Scholar
|
|
6
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
8
|
Zheng K, Liu W, Liu Y, Jiang C and Qian Q:
MicroRNA-133a suppresses colorectal cancer cell invasion by
targeting Fascin1. Oncol Lett. 9:869–874. 2015.PubMed/NCBI
|
|
9
|
Liu LY, Wang W, Zhao LY, Guo B, Yang J,
Zhao XG, Hou N, Ni L, Wang AY, Song TS, et al: Mir-126 inhibits
growth of SGC-7901 cells by synergistically targeting the oncogenes
PI3KR2 and Crk, and the tumor suppressor PLK2. Int J Oncol.
45:1257–1265. 2014.PubMed/NCBI
|
|
10
|
Guancial EA, Bellmunt J, Yeh S, Rosenberg
JE and Berman DM: The evolving understanding of microRNA in bladder
cancer. Urol Oncol. 32:41 e31–40. 2014. View Article : Google Scholar
|
|
11
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naito Y, Yasuno K, Tagawa H, Sakamoto N,
Oue N, Yashiro M, Sentani K, Goto K, Shinmei S, Oo HZ, et al:
MicroRNA-145 is a potential prognostic factor of scirrhous type
gastric cancer. Oncol Rep. 32:1720–1726. 2014.PubMed/NCBI
|
|
14
|
Liu Z, Xu Y, Long J, Guo K, Ge C and Du R:
microRNA-218 suppresses the proliferation, invasion and promotes
apoptosis of pancreatic cancer cells by targeting HMGB1. Chin J
Cancer Res. 27:247–257. 2015.PubMed/NCBI
|
|
15
|
Wang Y, Zhao W and Fu Q: miR-335
suppresses migration and invasion by targeting ROCK1 in
osteosarcoma cells. Mol Cell Biochem. 384:105–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS,
Choi KM and Um HD: Bcl-w promotes gastric cancer cell invasion by
inducing matrix metalloproteinase-2 expression via phosphoinositide
3-kinase, Akt and Sp1. Cancer Res. 66:4991–4995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong M, Ma J, Guillemette R, Zhou M, Yang
Y, Yang Y, Hock JM and Yu X: miR-335 inhibits small cell lung
cancer bone metastases via IGF-IR and RANKL pathways. Mol Cancer
Res. 12:101–110. 2014. View Article : Google Scholar
|
|
18
|
Tavazoie SF, Alarcon C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massague J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Bo L, Zhao X and Chen Q:
MicroRNA-133a inhibits cell proliferation, colony formation
ability, migration and invasion by targeting matrix
metallopeptidase 9 in hepatocellular carcinoma. Mol Med Rep.
11:3900–3907. 2015.PubMed/NCBI
|
|
20
|
Zabolotneva AA, Zhavoronkov A, Garazha AV,
Roumiantsev SA and Buzdin AA: Characteristic patterns of microRNA
expression in human bladder cancer. Front Genet. 3:3102012.
|
|
21
|
Wu D, Ding J, Wang L, Pan H, Zhou Z, Zhou
J and Qu P: microRNA-125b inhibits cell migration and invasion by
targeting matrix metallopeptidase 13 in bladder cancer. Oncol Lett.
5:829–834. 2013.PubMed/NCBI
|
|
22
|
Feng Y, Kang Y, He Y, Liu J, Liang B, Yang
P and Yu Z: microRNA-99a acts as a tumor suppressor and is
down-regulated in bladder cancer. BMC Urol. 14:502014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao J, Cai J, Huang D, Han Q, Yang Q, Li
T, Ding H and Wang Z: miR-335 represents an invasion suppressor
gene in ovarian cancer by targeting Bcl-w. Oncol Rep. 30:701–706.
2013.PubMed/NCBI
|
|
24
|
White NM, Bao TT, Grigull J, Youssef M,
Girgis A, Diamandis M, Fatoohi E, Metias M, Honey JR, Stewart R, et
al: miRNA profiling for clear cell renal cell carcinoma: biomarker
discovery and identification of potential controls and consequences
of miRNA dysregulation. J Urol. 186:1077–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dohi O, Yasui K, Gen Y, Takada H, Endo M,
Tsuji K, Konishi C, Yamada N, Mitsuyoshi H, Yagi N, et al:
Epigenetic silencing of miR-335 and its host gene MEST in
hepatocellular carcinoma. Int J Oncol. 42:411–418. 2013.
|
|
26
|
Wang L, Alcon A, Yuan H, Ho J, Li QJ and
Martins-Green M: Cellular and molecular mechanisms of pomegranate
juice-induced anti-metastatic effect on prostate cancer cells.
Integr Biol (Camb). 3:742–754. 2011. View Article : Google Scholar
|
|
27
|
Vickers MM, Bar J, Gorn-Hondermann I,
Yarom N, Daneshmand M, Hanson JE, Addison CL, Asmis TR, Jonker DJ,
Maroun J, et al: Stage-dependent differential expression of
microRNAs in colorectal cancer: potential role as markers of
metastatic disease. Clin Exp Metastasis. 29:123–132. 2012.
View Article : Google Scholar
|
|
28
|
Shu M, Zhou Y, Zhu W, Zhang H, Wu S, Chen
J and Yan G: MicroRNA 335 is required for differentiation of
malignant glioma cells induced by activation of cAMP/protein kinase
A pathway. Mol Pharmacol. 81:292–298. 2012. View Article : Google Scholar
|
|
29
|
Ronchetti D, Lionetti M, Mosca L, Agnelli
L, Andronache A, Fabris S, Deliliers GL and Neri A: An integrative
genomic approach reveals coordinated expression of intronic
miR-335, miR-342, and miR-561 with deregulated host genes in
multiple myeloma. BMC Med Genomics. 1:372008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W,
Zhou Y, Ou Y, Lin X, Lin Y, Xu D, et al: Targeting oncogenic
miR-335 inhibits growth and invasion of malignant astrocytoma
cells. Mol Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng Q, Cao H, Chen Z, Ma Z, Wan X, Peng
R and Jiang B: PAX6, a novel target of miR-335, inhibits cell
proliferation and invasion in glioma cells. Mol Med Rep.
10:399–404. 2014.PubMed/NCBI
|
|
32
|
Meng Y, Zou Q, Liu T, Cai X, Huang Y and
Pan J: microRNA-335 inhibits proliferation, cell-cycle progression,
colony formation, and invasion via targeting PAX6 in breast cancer
cells. Mol Med Rep. 11:379–385. 2015.
|
|
33
|
Shi L, Jiang D, Sun G, Wan Y, Zhang S,
Zeng Y, Pan T and Wang Z: miR-335 promotes cell proliferation by
directly targeting Rb1 in meningiomas. J Neurooncol. 110:155–162.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Z, Zhang Z, Liu Z, Qiu B, Liu K and
Dong G: MicroRNA-335 inhibits invasion and metastasis of colorectal
cancer by targeting ZEB2. Med Oncol. 31:9822014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao Y, Zeng F, Wu JY, Li HY, Fan JJ, Mai
L, Zhang J, Ma DM, Li Y and Song FZ: MiR-335 inhibits migration of
breast cancer cells through targeting oncoprotein c-Met. Tumour
Biol. 36:2875–2883. 2015. View Article : Google Scholar
|
|
36
|
Gao L, Yang Y, Xu H, Liu R, Li D, Hong H,
Qin M and Wang Y: MiR-335 functions as a tumor suppressor in
pancreatic cancer by targeting OCT4. Tumour Biol. 35:8309–8318.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsui T, Amano M, Yamamoto T, Chihara K,
Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A and Kaibuchi K:
Rho-associated kinase, a novel serine/threonine kinase, as a
putative target for small GTP binding protein Rho. EMBO J.
15:2208–2216. 1996.PubMed/NCBI
|
|
39
|
Montalvo J, Spencer C, Hackathorn A,
Masterjohn K, Perkins A, Doty C, Arumugam A, Ongusaha PP,
Lakshmanaswamy R, Liao JK, et al: ROCK1&2 perform overlapping
and unique roles in angiogenesis and angiosarcoma tumor
progression. Curr Mol Med. 13:205–219. 2013. View Article : Google Scholar :
|
|
40
|
Kamai T, Tsujii T, Arai K, Takagi K, Asami
H, Ito Y and Oshima H: Significant association of Rho/ROCK pathway
with invasion and metastasis of bladder cancer. Clin Cancer Res.
9:2632–2641. 2003.PubMed/NCBI
|
|
41
|
Xue F, Takahara T, Yata Y, Xia Q, Nonome
K, Shinno E, Kanayama M, Takahara S and Sugiyama T: Blockade of
Rho/Rho-associated coiled coil-forming kinase signaling can prevent
progression of hepatocellular carcinoma in matrix
metalloproteinase-dependent manner. Hepatol Res. 38:810–817. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lane J, Martin TA, Watkins G, Mansel RE
and Jiang WG: The expression and prognostic value of ROCK I and
ROCK II and their role in human breast cancer. Int J Oncol.
33:585–593. 2008.PubMed/NCBI
|
|
43
|
Vishnubhotla R, Sun S, Huq J, Bulic M,
Ramesh A, Guzman G, Cho M and Glover SC: ROCK-II mediates colon
cancer invasion via regulation of MMP-2 and MMP-13 at the site of
invadopodia as revealed by multiphoton imaging. Lab Invest.
87:1149–1158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lock FE, Ryan KR, Poulter NS, Parsons M
and Hotchin NA: Differential regulation of adhesion complex
turnover by ROCK1 and ROCK2. PLoS One. 7:e314232012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lynch J, Fay J, Meehan M, Bryan K, Watters
KM, Murphy DM and Stallings RL: MiRNA-335 suppresses neuroblastoma
cell invasiveness by direct targeting of multiple genes from the
non-canonical TGF-beta signalling pathway. Carcinogenesis.
33:976–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar :
|
|
50
|
Lin SL, Chiang A, Chang D and Ying SY:
Loss of mir-146a function in hormone-refractory prostate cancer.
RNA. 14:417–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
